My bookmarksSign up free

Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Regulation (EU) 2022/1255 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Antimicrobials or groups of antimicrobials designated as reserved for treatment of certain infections in humans

Article 1

1.   The antimicrobials and groups of antimicrobials listed in the Annex shall not be used in veterinary medicinal products or medicated feed. 2.   The use in animals of medicinal products for human use that contain any of the antimicrobials or groups of antimicrobials listed in the Annex is prohibited.

Entry into force and application

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 9 February 2023.

Supplementary provisions

Antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans

ANNEXSupplementary provisions

ANNEX Antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans (1)    Antibiotics (a) Carboxypenicillins (b) Ureidopenicillins (c) Ceftobiprole (d) Ceftaroline (e) Combinations of cephalosporins with beta-lactamase inhibitors (f) Siderophore cephalosporins (g) Carbapenems (h) Penems (i) Monobactams (j) Phosphonic acid derivates (k) Glycopeptides (l) Lipopeptides (m) Oxazolidinones (n) Fidaxomicin (o) Plazomicin (p) Glycylcyclines (q) Eravacycline (r) Omadacycline (2)    Antivirals (a) Amantadine (b) Baloxavir marboxil (c) Celgosivir (d) Favipiravir (e) Galidesivir (f) Lactimidomycin (g) Laninamivir (h) Methisazone/metisazone (i) Molnupiravir (j) Nitazoxanide (k) Oseltamivir (l) Peramivir (m) Ribavirin (n) Rimantadine (o) Tizoxanide (p) Triazavirin (q) Umifenovir (r) Zanamivir (3)    Antiprotozoals (a) Nitazoxanide

Other acts of the same type
Commission Implementing Regulation (EU) 2021/419 of 9 March 2021 amending Implementing Regulation (EU) 2018/2019 as regards certain plants for planting of Jasminum polyanthum Franchet originating in Israel and adapting Combined Nomenclature codes for Ullucus tuberosus and amending Implementing Regulation (EU) 2020/1213 as regards the phytosanitary measures for the introduction of those plants for planting into the Union territoryCommission Implementing Regulation (EU) 2021/420 of 9 March 2021 correcting Implementing Regulation (EU) 2020/1097 concerning the authorisation of lutein-rich and lutein/zeaxanthin extracts from Tagetes erecta as feed additives for poultry (except turkeys) for fattening and laying and for minor poultry species for fattening and laying (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/421 of 9 March 2021 concerning the authorisation of tincture derived from Artemisia vulgaris L. (mugwort tincture) as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/422 of 9 March 2021 concerning the authorisation of a preparation of Enterococcus faecium DSM 7134 as a feed additive for laying hens (holder of authorisation: Lactosan GmbH & Co KG) (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/425 of 9 March 2021 suspending commercial policy measures concerning certain products from the United States of America imposed by Implementing Regulation (EU) 2020/1646 following the adjudication of a trade dispute under the Dispute Settlement Understanding of the World Trade OrganizationCommission Implementing Regulation (EU) 2021/413 of 8 March 2021 renewing the approval of the low-risk active substance blood meal in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/797 of 8 March 2021 correcting certain language versions of Annex II and Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/805 of 8 March 2021 amending Annex II to Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)Council Implementing Regulation (EU) 2021/397 of 5 March 2021 implementing Regulation (EU) No 1352/2014 concerning restrictive measures in view of the situation in YemenCommission Delegated Regulation (EU) 2021/880 of 5 March 2021 amending Delegated Regulation (EU) 2020/686 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards the traceability, animal health and certification requirements for movements within the Union of germinal products of certain kept terrestrial animals (Text with EEA relevance)Council Implementing Regulation (EU) 2021/391 of 4 March 2021 implementing Regulation (EU) No 208/2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in UkraineCommission Implementing Regulation (EU) 2021/392 of 4 March 2021 on the monitoring and reporting of data relating to CO2 emissions from passenger cars and light commercial vehicles pursuant to Regulation (EU) 2019/631 of the European Parliament and of the Council and repealing Commission Implementing Regulations (EU) No 1014/2010, (EU) No 293/2012, (EU) 2017/1152 and (EU) 2017/1153 (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next